Login  
Volume 63
 2002
Supplement 9

Articles   [top]

3  Introduction: Cardiovascular and Metabolic Risks Associated With Schizophrenia and Antipsychotic Drug Treatment [Free Access]

[Full Text]

5  Risk of Cardiovascular Disease and Sudden Death in Schizophrenia [Free Access]

[Full Text]

12  Clinical Management of Cardiovascular Risks During Treatment With Psychotropic Drugs [Free Access]

[Full Text]

18  Mechanisms and Risks of Electrocardiographic QT Interval Prolongation When Using Antipsychotic Drugs [Free Access]

[Full Text]

25  Assessing Cardiovascular Risks Versus Clinical Benefits of Atypical Antipsychotic Drug Treatment [Free Access]

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx